130,379 Shares in InfuSystem Holdings, Inc. $INFU Purchased by Man Group plc

Man Group plc bought a new stake in shares of InfuSystem Holdings, Inc. (NYSE:INFU) in the 2nd quarter, HoldingsChannel.com reports. The institutional investor bought 130,379 shares of the company’s stock, valued at approximately $1,258,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Hsbc Holdings PLC increased its position in InfuSystem by 5.7% in the 1st quarter. Hsbc Holdings PLC now owns 30,097 shares of the company’s stock worth $281,000 after buying an additional 1,619 shares during the period. Geode Capital Management LLC boosted its position in shares of InfuSystem by 0.8% in the fourth quarter. Geode Capital Management LLC now owns 218,123 shares of the company’s stock valued at $1,958,000 after acquiring an additional 1,831 shares during the period. HighTower Advisors LLC boosted its position in shares of InfuSystem by 13.8% in the fourth quarter. HighTower Advisors LLC now owns 21,061 shares of the company’s stock valued at $189,000 after acquiring an additional 2,561 shares during the period. Integrated Quantitative Investments LLC grew its stake in shares of InfuSystem by 6.9% in the fourth quarter. Integrated Quantitative Investments LLC now owns 41,484 shares of the company’s stock worth $372,000 after acquiring an additional 2,684 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd grew its stake in shares of InfuSystem by 25.8% in the fourth quarter. Dynamic Technology Lab Private Ltd now owns 13,724 shares of the company’s stock worth $123,000 after acquiring an additional 2,811 shares during the last quarter. Institutional investors and hedge funds own 71.13% of the company’s stock.

InfuSystem Price Performance

InfuSystem stock opened at $12.14 on Thursday. The company has a market capitalization of $245.01 million, a PE ratio of 202.37 and a beta of 1.50. The business has a 50 day simple moving average of $10.66 and a 200 day simple moving average of $9.78. InfuSystem Holdings, Inc. has a one year low of $7.29 and a one year high of $12.97. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59.

InfuSystem declared that its Board of Directors has initiated a stock buyback plan on Tuesday, May 19th that allows the company to repurchase $20.00 million in shares. This repurchase authorization allows the company to buy up to 10.2% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s board believes its stock is undervalued.

Wall Street Analysts Forecast Growth

Separately, B. Riley Financial reiterated a “buy” rating and set a $20.00 target price (up from $12.00) on shares of InfuSystem in a research note on Wednesday, August 5th. Three equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $16.67.

About InfuSystem

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.